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Introduction 
 
The retinal pigment epithelium (RPE) is a layer of tissue found in the vertebrate eye 
between Bruch’s membrane and the photoreceptor layer of the neural retina [1]. It is derived 
from the outer layer of the optic cup [2], possesses an innate immune system [3], and consists of 
a monolayer of highly pigmented cells that fit together in a tight matrix (fig. 1) [4]–[6]. The 
monolayer is often compared to a mosaic or cobblestones in its configuration, while the shape of 
the individual cells is usually described as polygonal/hexagonal, columnar (aligned 
perpendicular to the underlying membrane), or “epithelioid”. The cells are strongly polarized[7], 
with microvilli on the apical surface [8]. Despite its simplicity as a tissue layer, the RPE plays 
many complex roles in the vertebrate eye, including regulation of retina development [9], [10], 
absorbing excess light entering the eye to reduce photo-oxidative stress[11], secreting growth 
factors such as vascular endothelial growth factor (VEGF)[5], [10], [12], mediating the immune 
response of the eye [13]–[15], transporting metabolites and fluids [16]–[18], and phagocytosing 
spent rod and cone outer segments [19]–[26]. The RPE also acts as an intermediate for supplying 
glucose and other vital nutrients to the retina [27] while maintaining a good environment for the 
photoreceptors [28] and preventing large molecules from entering the eye from the bloodstream 
[29]. This last purpose designates the RPE as part of the blood-retinal barrier, which is primarily 
in place to stop particles from entering the vitreous humor and obscuring vision [30]–[32]. While 
the RPE plays many roles in the eye, its greatest medical significance comes from its 
involvement in many ocular disorders [33] that can lead to vision loss or blindness, such as 
retinitis pigmentosa, diabetic retinopathy, West Nile virus, and macular degeneration [12], [34]–
[46]. 
 
Figure 1. Diagram of the outer retina, showing the retinal pigment epithelium and its location between Bruch’s 
membrane and the neural retina. Pigment granules, tight junctions, and monolayer formation are indicative of 
natural-type RPE cells. [34] 
 
Macular degeneration in particular is currently of great interest to medical and biological 
researchers. Age-related macular degeneration (AMD) is a disorder of the retina characterized by 
loss of sight in the center of the visual field, and is the leading cause of vision loss after age 50 in 
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developed countries [47]. AMD occurs in two forms: the exudative or “wet” form, and the 
nonexudative or “dry” form. Wet AMD (the most severe form, also called choroidal 
neovascularization) is caused by excessive growth of capillaries from the choroid and into 
Bruch’s membrane and the RPE in response to production of vascular endothelial growth factor 
(VEGF)[48]. These fragile new blood vessels exude blood, lipid, and protein below the macula 
(the central region of the retina, necessary for visual acuity), causing scarring and sudden acute 
vision loss [49]. Dry AMD (the most common type, also called atrophic AMD or geographic 
atrophy)[50] is a much slower process, characterized by degeneration of the RPE and later the 
neural retina [49], [51], [52], which can lead in some cases to tearing of the RPE [53]. Its causes 
are not fully understood [29] [30], although evidence suggests contributing factors include the 
accumulation of lipofuscin and other substances in the eye [32], [56]–[61], disruption of 
autophagy and other processes in the RPE [23], [26], [62]–[64], photo-oxidative stress caused by 
excess light entering the eye [32], [60], [65]–[71], and other retinal disorders like focal choroidal 
excavation (FCE)[72]. 
Both AMD types are characterized by the deposition of soft drusen between the RPE and 
Bruch’s membrane [73]–[76], as well as hypo- and hyperpigmentation of the RPE itself [51][77]. 
This, along with chemical evidence [27] [35]–[39], suggests that the RPE is the site of origin of 
AMD development, and that research and experimentation with this particular tissue layer is 
necessary for learning more about this crippling disease [83]–[86]. 
While AMD research has been conducted for many years, there is still no available 
chemical or surgical treatment for reversal of vision loss in the dry form of the disease [48], [52], 
[87], [88]). Many researchers are exploring possibilities for treatment, such as slowing 
deterioration in the intermediate stage through high doses of vitamin supplements such as lutein 
and zeaxanthin [89], treatments like laser photocoagulation [47], use of stem cells to replaced 
degraded cells[90]–[94], and even gene therapy [67], [95]. However, because RPE cells are 
largely non-proliferative throughout life, regeneration and repair of the already-damaged tissue is 
normally impossible [35]. Before an effective treatment can be found for AMD, further 
experimentation must be performed in order to fully understand the role of the RPE in AMD 
inception and progression. While necessary for visual function, the blood-retinal barrier also 
makes chemical experimentation with AMD treatment unproductive because it inhibits drug 
treatments from passing from the blood to the vitreous humor[96]. This, as well as its location at 
the back of the eye, makes observation of and experimentation with the RPE difficult in vivo[97]. 
 One possible alternative to in vivo RPE research is to culture RPE cells in vitro [98]–
[100]. RPE cell culture has been practiced for over forty years at the time of this writing [101] 
and over the decades many methods for producing viable RPE cells have been demonstrated. 
While RPE cells are normally non-proliferative in adults, they can be induced to re-enter their 
glycolytic metabolism stage in which proliferation, migration, and differentiation is possible, 
allowing them to re-establish a viable monolayer in medium [102]–[104]. Cultured RPE cells can 
be used in a variety of applications, many of which can be used in AMD research [28]. One, as 
intimated above, is the use of cultured RPE cells as a testing ground for AMD drug treatments. A 
researcher searching for a possible cure for AMD could induce atrophy in the RPE monolayer 
before introducing various chemicals or supplements to observe their effect on the cultured cells. 
Such an experimenter would most likely desire an RPE culture in which the orientation, 
configuration, and morphology of the cells are similar to those found in the natural RPE. The 
culture would fulfill its function most effectively if it produced a dense monolayer of epithelioid 
cells with dark pigmentation and tight intercellular junctions, similar to the in vivo RPE [105]. 
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However, despite the amount of time and energy that has been spent on improving RPE culturing 
techniques, difficulties still arise as scientists attempt to produce a pigmented, epithelioid 
monolayer that best mimics native RPE tissue. RPE cells may exhibit considerable phenotypic 
variation depending on their growth conditions [106]. Some of the most common problems are 
loss of pigmentation in the cultured cells, low cell-substrate adhesion rate, alterations in cell 
morphology (in particular, a tendency for epithelioid cells to transform into long, fibroblast-like, 
“fusiform” cells) [19], and low yield of viable cells from those harvested [107]. Many of these 
problems can be attributed to variations in cell seeding density, freshness (for cells grown from 
living tissue), culture medium composition, incubation conditions, passage number [50], and 
substrate topography[108], and any researcher attempting to closely replicate native RPE tissue 
in vitro would be well advised to search published protocols for the right procedure. 
Another application for RPE culture is the cultivation of cells intended for direct RPE 
transplant, a line of research already being explored by several groups [87], [109]–[112]. RPE 
transplantation experiments have been performed using in vivo harvested cells from the same 
patient [113], [114] and research oriented toward growing layers of healthy RPE tissue that can 
be transplanted into the eyes of patients suffering from AMD to replace any damaged or 
atrophied cells is a growing field [115]. While this course of action may be effective in curing 
AMD, at least temporarily, it would also require donor/transplant compatibility, invasive ocular 
surgery, a substrate that can be transplanted with the cells (since experiments using RPE cell 
suspensions and loose sheets injected directly into the eye have been largely unsuccessful) [87], 
[116], and an even higher standard of monolayer fidelity and morphological similarity to the 
human eye than a culture grown for experimentation. Nevertheless, many researchers [47], [87], 
[117]see RPE transplant as a viable method for treating AMD, and have developed culture 
protocols accordingly. 
One phenomenon that has been observed by RPE researchers is the tendency for cultured 
RPE cells to spontaneously transform into cell lines [118]. RPE cell lines are often characterized 
by extended cell life, changes in cell morphology, and sometimes immortality. While this makes 
them useful for extended experimentation, it renders them unsuitable for transplantation, and in 
addition may not produce as accurate results in a drug treatment research. Culture protocols that 
give rise to cell lines, therefore, are best suited for RPE research that allows for morphological 
differences between the culture and natural RPE. 
Another cell transformation phenomenon that has been reported in RPE cell cultures is 
the activation of ordinary RPE cells into stem cells [35], [119]–[121]). The RPE begins life as a 
plastic tissue that is originally capable of producing lens and retina in some species, but quickly 
loses this competency as it differentiates into largely non-proliferative RPE cells [122], [123]. 
However, either by active induction or spontaneously, RPE cells in culture have shown the 
ability to transform into self-renewing multipotent cells that can give rise to optical, neural, and 
mesenchymal tissue under certain conditions [35], [124]. This opens up another avenue of AMD 
research: producing new RPE cells and perhaps neural retina tissue from retinal pigment 
epithelial stem cells (RPESCs) to replace those damaged by the disease, even in vivo. Under 
ordinary circumstances, human RPE cells do not replace themselves when damaged, unlike in 
some other species, where injury to the eye can result in the RPE not only regenerating itself but 
also neural retina [35], [125]. The transformation of RPE cells into stem cells is often marked by 
the appearance of spheroid colonies that detach from the substrate and float, and cells recultured 
from floating colonies have shown self-renewing properties [120]. Activation of these latent 
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plastic properties may aid in recovery of AMD patients without the need for entire RPE sheet 
transplants.  
With these four applications (drug experimentation, transplants, cell line and stem cell 
generation) there is ample opportunity for RPE cell cultures to be used in AMD research. 
However, not every cell culture method will be right for every application. For example,  since 
self-differentiating multipotent RPE cells are suspected to be the source of mesenchymal cell 
fates in disorders such as proliferative vitreoretinopathy (PVR) [120], a cell culture that is 
conducive to the spontaneous production of stem cells may not be suitable for transplants. The 
same way, a transformed cell line may be useful for some experimentation, but the 
morphological and growth changes that accompany transformation may make the cells too 
different from natural RPE to be used in drug treatment tests or transplants. For this reason, a 
researcher must be careful to select a culturing protocol that will best suit the needs of their 
project.  
The purpose of this literature review is to examine the various protocols that have been 
developed and used since the earliest days of RPE culture and to compare different methods 
(including cell source and harvesting procedure, culture medium and substrate, incubation 
conditions, and passage method) so that researchers attempting to culture RPE cells can have a 
ready reference to aid in selecting the protocol that is best for them. Research into culturing 
retinal pigment epithelium tissue is divided into two main branches, based on cell sources: 
cultures grown from harvested tissue, and those grown from established cell lines (while the 
generation of RPE cells from stem cells is a third possibility [91], [115], [126], [127], this review 
will focus on the previous two methods). This review will first examine cultures using donor 
organisms as a cell source, then the culturing procedures of cell lines. 
 
Cells obtained from tissue 
 
 Before the establishment of cell lines, the only possible source for researchers trying to 
culture RPE cells was from the tissue of living and recently-deceased vertebrates. When 
cultivating such cells, the basic procedure is to first harvest the cells from the tissue, usually with 
the help of some sort of digestive enzyme to degrade the structural proteins holding the cells in 
place. Often this requires removal of the eye from the surrounding tissue (enucleation) and 
dissection of the eye globe, most commonly by cutting off the anterior portion of the eyeball (see 
fig. 2) and leaving an “eyecup”, with the RPE at the bottom, into which digestive enzymes (such 
as trypsin and dispase, two of the most common proteins used) can be poured [128]. An 
alternative (sometimes used in conjunction with enzymatic digestion) is to remove the RPE from 
the eye through mechanical means, such as with forceps or dissection blades, often in a single 
sheet or fragments of a sheet. This can often lead to contamination from choroidal cells, but is 
beneficial in that it may maintain the epithelial mosaic-like structure of the RPE. After cell 
harvesting, the next step is usually to transfer the cells into a culture medium and allow them to 
adhere to a substrate that is conducive to the growth of a cellular monolayer. Incubation follows, 
usually at a set of standard conditions common to mammalian cell cultures (~37°C, 5% CO2). If 
the cells are allowed to grow to confluence, they are usually passaged, again using a mild 
digestive enzyme to dissolve them from the substrate, with a certain number of passages possible 
before cell senescence and death.  
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Figure 2. Schematic of the vertebrate eye, with vertical dashed line to illustrate where incision is usually made when 
creating an “eyecup” from which RPE cells are harvested. [35] 
 
 Generally, the benefit of using tissue as a cell source is that the cells are already in the 
tiled configuration found in the eye, encouraging the cells to continue to grow in a single 
monolayer that best matches the natural structure of the RPE. However, as cells are often 
dissolved from their configuration and resuspended in culture medium, a greater benefit is that 
the cells may maintain their morphology and pigmentation, which are often lost when using 
transformed cells from cell lines. In the following sections, established protocols for cultivating 
cells obtained from humans (living, dead, adult, and fetal) will be examined, followed by 
cultures of cells taken from nonhuman vertebrates. 
 
 
Figure 3. Dissected human fetal eye cup, with neural retina removed and RPE cells visible as dark layer on quartered 
tissue. [34] 
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Human donors 
 
The human RPE is, of course, the best model for testing treatments for human ailments, 
and is also the acceptable source for human RPE transplants, cell lines, and stem cells. Culturing 
of human RPE has been going on since the 1970s [101], and many of the practices developed 
then are still in use today, particularly the method for harvesting cells from the human eye. In the 
early days, Mannagh et al. (1973) cultured RPE cells in an experiment simply to discover the 
suitability of human RPE for lab culture, and used a cell-harvesting method still commonly 
practiced today by RPE researchers. The adult human RPE were extracted from eyes harvested 
for corneal transplants that had either been found unsuitable for transplantation or had already 
had the cornea removed. The eyes were first dissected by removing the anterior half of the globe 
6 mm behind the limbus (see fig. 2) and the resulting posterior eyecup inverted, removing the 
vitreous body and retina. The RPE was then digested enzymatically, using 0.03% Pronase (a 
commercial mixture of proteases derived from Streptomyces griseus) in a calcium and 
magnesium-free balanced salt solution. The cup was filled with about 5 ml of the Pronase 
solution and incubated at 37°C for 20 to 30 minutes, freeing the RPE cells from the Bruch’s 
membrane. The cells were then harvested by repeated aspiration of the Pronase solution through 
an 18-gauge needle on a 5 ml syringe, and the resulting suspension centrifuged at 1,000 rpm for 
3 minutes. During this time, the Bruch’s membranes of the eyes were examined and found to be 
intact, verifying that no fragments of membrane had been harvested with the cells. After 
centrifuging, the supernatant solution was pipetted off and the cell pellet resuspended in 1 ml of 
15% FBS-Eagle’s minimum essential medium (EMEM), and the new suspension placed in a 
Rose chamber or T25 flask filled with the same medium. Mannagh et al. noted a negative 
relationship between the age of the donor and the viability of the culture, with 75% success (57 
out of 76 cultures) for donors under 60 years but only 58% (62 of 106 cultures) for donors over 
60. Interestingly, in the case of eight pairs of eyes used as cell sources, only one eye in each pair 
gave rise to a viable culture. The viable cultures were found to form small adherent clusters of 
round, heavily pigmented cells on the floor of the container 48 hours after inoculation, when 
mitotic activity was also detected. After cells were observed, the medium was changed to remove 
the free-floating pigment granules that had escaped into the solution. Mitosis continued for about 
30 days, when a confluent monolayer would completely form on the floor of a Rose chamber. 
Pigmentation loss was noted with each cell division, and attempts to stimulate pigment formation 
by the addition of adrenocorticotrophic hormone (ACTH, 0.5 U/ml) were unsuccessful. The 
researchers observed spontaneous transformation of primary cultures into cell lines in seven 
cases, all of which resulted in a change in cell morphology to a smaller, more uniform shape and 
accelerated growth. These cell lines were successfully passaged and seeded at 1x105 cells/ml. 
This protocol demonstrated the culturing potential of RPE cells and their ability to spontaneously 
produce cell lines, and while somewhat less-refined than later protocols is still effective for a 
researcher merely wishing to culture RPEs for practice or for the purpose of cell line production. 
Around the same time, Tso et al. (1973) cultured RPE cells to discover the extent of 
morphological changes experienced by RPE cells upon removal from Bruch’s membrane. The 
cells were obtained from both cadavers and from living patients whose eyeballs were enucleated 
for melanoma and retinoblastoma. The eyes were opened in culture medium RPMI (Roswell 
Park Memorial Institute medium) 1640, with the RPE and uvea separated together from the 
sclera, placed on a Millipore filter (EMD Millipore, Billerica, MA, USA) choroid-down, and 
kept within the medium for the remainder of the procedure. The cultures were placed in Leighton 
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tubes filled with 2 ml of the same medium and incubated at 37°C, with medium changes twice a 
week. For the first 3 days, the cells retained epithelial properties and pigmentation, with some 
less-pigmented cells noted over time. After 3 days to 6 weeks in culture, the tissues were fixed in 
2% glutaraldehyde. The adult cultures also had thorotrast added 24 hours after the culture began. 
After fixation, the tissues were postfixed in Dalton’s chrome osmium fixative for one hour and 
embedded in Epon. When cells were observed using light and electron microscopy, no difference 
was found in the growth between cells taken from dead or living donors, and the RPE cell shapes 
were found to become more irregular after three days, with no spreading observed, with 
attenuation and necrosis after 6 weeks. The cultures to which thorotrast had been added 
displayed the ability to phagocytose the thorotrast particles (one of the functions of natural RPE 
cells), which were engulfed in discrete vesicles after 2 days of incubation. This culture method is 
recommended for an experimenter attempting to produce a more natural-type RPE monolayer for 
drug experimentation. 
Aronson (1983) attempted to identify a consistent procedure for culturing human RPE 
cells by using choroid fragments as the seeding vehicle. The choroid fragments were harvested 
24 hours after delivery from human aborted fetuses 3-4 months into gestation; they were 
removed by bisecting the eye through the optic stalk, pulling off the retina with forceps, and then 
peeling off the RPE and choroid as a single sheet. The sheet was minced with a scalpel and the 
fragments plated on tissue culture plastic in a small volume of modified MEM medium, and after 
1 to 2 days partially-rounded fragments were isolated and placed on non-tissue-culture plastic 
Petri dishes. The fragments were cultured until they formed spheres. The spheres were then 
plated on tissue culture plastic in a small volume of medium and allowed to grow for 7 days 
before the tissue fragment was removed, leaving a new cell line on the plastic. This method of 
including choroidal fragments in the seeding culture is still used by some researchers [9], and is 
recommended for researchers looking to start cell lines, although occasionally experimenters 
report problems from contaminating choroidal cells. 
Oka et al. (1984) compared the effects of traditional serum-supplemented medium and 
serum-free defined medium on both human and bovine RPE cells grown in culture. In this 
section, the human cells will be considered. The cells were isolated by taking enucleated eyes 
and rinsing them in 95% ethanol and Sal FM, then removing the anterior section of the eyeball 
and vitreous, as previously described in Mannagh et al. (1973). The eye cup was rinsed with 
warm Sal FM three times and the neural retina removed, after which each eye cup was filled with 
3-5 ml CTH (a mixture of 2% (v/v) chicken serum, 0.25% (w/v) trypsin, and 0.1 (w/v) 
hyaluronidase in calcium- and magnesium-free Puck’s Saline F) and allowed to incubate for 30 
min at 37°C. This incubation period allowed the RPE cells to disperse into the CTH in a 
suspension, which was then removed and centrifuged lightly in equal volumes of a medium 
composed of DME-F12 medium supplemented with 20% (v/v) FBS (designated CM medium). 
After centrifuging, the supernatant was removed and the cell pellet resuspended in CM. The 
process of dispersal, centrifuging, and resuspension was repeated several times until all 
suspensions were pooled in warm CM. For the final culture, one of two media were used: either 
CM or defined medium (DME-F12 supplemented with 5.0 µg insulin/ml, 5.0 µg transferrin/ml, 
8.0 ng epidermal growth factor/ml, 0.5 mU follicle stimulating hormone/ml, and 50 ng all-trans 
retinoic acid/ml) (DM). As with most methods listed, the cells were incubated in a 5% CO2 
atmosphere at 37°C, and the media was changed every 2-3 days. The cells were cultured on 60 
mm culture dishes and passaged using 0.25% trypsin. The effects of the serum (CM) versus 
serum-free medium (DM) were observed and recorded. Results showed that plating efficiency 
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was consistently higher in a 1:1 DME:F12 mixture than in either DME or F12 alone. It was also 
observed that the highest plating efficiency was achieved when the 1:1 mixture was 
supplemented with 20% FBS (CM, as designated above). Pure DME medium was found to result 
in larger, less numerous colonies of RPE cells, while pure F12 resulted in smaller, more 
numerous colonies. The CM mixture resulted in a doubling time of approximately 50 hours, 
which diminished in later passages to 20-25 hours and in very late passages increased to 100 
hours. Fourth passage cells were found in many instances to stop dividing before confluence. 
Despite the attempt to completely eliminate serum from the culturing process (due to the 
introduction of hormones and other factors that may affect cell development) [9], serum-
containing medium (CM) was found to be necessary for cell attachment and spreading, though 
using serum-free DM after the initial 24-hour plating period in CM resulted in exponential 
growth. This procedure is recommended for cultivation of RPE cells for drug experimentation, 
since it produces a viable cell culture that is similar to natural-type RPE. 
Hunt et al. (1989) were able to form viable cultures using cells extracted from eyes 
donated for corneal transplant, all from humans less than 40 years old. The eyes were first 
dissected by removal the anterior portion of the eye globe, vitreous, lens, and neural retina to 
expose the RPE, which they then rinsed with Hank’s basal salt solution (HBSS). They then filled 
the eyecup with 0.5 g trypsin/0.2 g EDTA/ml and incubated it at 37º C for 15 minutes. The 
detached cells were then aspirated off and trypsin digestion repeated. All removed cells were 
then washed in Ham’s F-10 medium supplemented with 20% FBS, ITS plus (Collaborative 
Research), antibiotics, and a retina extract made by incubating human retina and vitreous in 
growth medium followed by filtration. The cells were resuspended in this same medium, and 
seeded onto a variety of surfaces, among which are listed multi-well tissue culture dishes, 
Millicell (EMD Millipore, Billerica, MA, USA) or Costar (Sigma-Aldrich, St. Louis, MO, USA) 
culture well inserts, and polycarbonate fibers. All culture surfaces were received a coating to test 
cell adhesion, with different coatings tested including laminin, fibronectin, type IV collagen, and 
Matrigel (an extracellular matrix exudate from a tumor cell line). The extraction process yielded 
high concentrations of pigmented cells, with some erythrocytes mixed in in some cases, and it 
was found that when seeded onto the plating surfaces the RPE cells adhered rapidly, with non-
adhering cells being removed and the medium changed after 48 hours. The cells were maintained 
in medium until they grew to confluence, the time required for which depended on both the 
seeding concentration and the donor. Results showed that the laminin-coated substrates (which 
were coated in 20 µg/ml laminin in Ham’s F-10 medium) yielded the greatest cell growth, with 
cells forming highly pigmented epithelioid monolayers with intercellular junction complexes as 
seen in the natural RPE. This was determined to be due to the fact that laminin is a component of 
basal RPE lamina and is thought to be involved in cell adhesion. This protocol is recommended 
for drug experimentation studies, particularly due to the natural-type intercellular junctions 
produced by the procedure, which may be useful in experiments involved with circumventing the 
blood-retinal barrier. 
Tezel and Priore (1998) attempted to develop a chemically-defined serum-free medium 
(CDSFM) to avoid the problems associated with the use of serum in RPE culture, similar to 
[132] (see above). They used cadaver eyes incubated in 25 U/ml dispase for 30 minutes after the 
same dissection used by Mannagh et al. (1973). The RPE and choroid were removed together 
using forceps, and the loosened RPE sheets pipetted off and placed in CDSFM, a 1:1 mixture of 
DMEM:F12 with pyridoxine HCl, L-glutamine, and 15mM of HEPES buffer, supplemented with 
insulin, transferring, epidermal growth factor, follicle stimulating growth hormone, retinoic acid, 
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sodium selenite, hydrocortisone, tri-iodothyronine, streptomycin, penicillin, gentamycin, 
amphotericin, linoleic acid (10 µg/ml), and putrescine (0.3 µg/ml) (see publication for further 
preparation details). The RPE cells were then centrifuged at 1000 RPM for 5 minutes and the 
pellet resuspended in CDSFM or DMEM before inoculation on bare or bovine corneal 
endothelial extracellular matrix (BCE-ECM)-coated tissue culture plastic wells. The cells were 
incubated in 5% CO2 at 37°C and the medium changed every other day. Researchers found the 
cells to be confluent after 9-15 days on BCE-ECM and 16-26 days on bare tissue culture plastic 
(fig. 4). Passaging of confluent cultures took place by trypsinization and subsequent trypsin 
deactivation by addition of aprotinin. Results showed higher seeding efficiency on BCE-ECM 
than on ordinary tissue culture plastic, and that the cells formed fewer non-hexagonal (fusiform) 
morphologies. Researchers observed higher proliferation rates for the RPE cells in DMEM with 
serum than in CDSFM. This culture technique is recommended for drug experimentation, due to 
the generally epithelioid structure of the resulting cells. 
 
 
Figure 4. Morphology of RPE cells grown in CDSFM by Tezel and Priore (1998). (A) Cells at the edge of primary 
RPE sheets began to flatten on day one (arrows). (B) Densely-packed RPE cells grown to confluence on BCE-ECM, 
with edge of primary RPE sheet shown by arrow. (C) RPE cells grown on tissue-culture plastic, also densely-
packed. (D) Second-passage RPE cells grown to confluence on BCE-ECM, with fusiform cells indicated by arrows. 
(E) Second passage RPE cells on tissue-culture plastic, with greater number of fusiform cells than BCE-ECM. (F) 
Third-passage RPE cells on tissue-culture plastic, with a greater number of fusiform cells. Magnification x 100 for 
all photographs. [133] 
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Singh et al. (2001) [87] cultured human RPE cells to be specifically used for 
transplantation to treat AMD, experimenting with two separate substrates (human lens capsule 
tissue and hydrogel) to use in the transplants. The lens capsules were taken from 55-year-old-
and-older patients undergoing cataract surgery and stored in HBSS at 4ºC until used, with the 
lens epithelial cells scraped off from the capsule surface using soft-tipped silicon tubing. After 
cell removal was confirmed by examination under an inverted phase microscope, the capsules 
were laid epithelial-side up in 24-well tissue culture dishes. The hydrogels (manufactured by 
Organogel Canada L. Tee, Quebec) were prepared by free radical co-polymerization of 
methacrylate and (meth)acrylamide precursor monomers (ratio 1/0.41 by weight), with ethylene 
glycol dimethetacrylate as a crosslinking agent. Polymerization occurred between two pre-
cleaned glass microscope slides spaced by a coverslip for 4 hours at 35ºC, after which the 
polymer membranes were peeled and washed in distilled water until equilibrium swelling. The 
swollen gels were cut into circular disks by a cork borer and then sterilized by autoclaving and 
stored in distilled water. The final water content of the hydrogels was 60%, for a thickness of 
approximately 25 µm. The hydrogels were then coated with extracellular matrix factors by being 
placed in a well plate with 1 ml of poly-D-lysine (MW 540,000, 20 µg/L) and HBSS for 5 
minutes, after which the solution was aspirated off and the hydrogels were incubated overnight at 
37ºC in 2 ml fibronectin solution (20 µg/ml) in HBSS. The day after this solution was aspirated 
off as well and the hydrogel allowed to dry for 30 minutes under UV light (256.7 nm) in a tissue 
culture hood. The RPE cells themselves were extracted from eyes of cadavers 65-70 years old, 
obtained 8-24 hours after death, using the dissection method found in [129], after which the 
eyecup was washed with HBSS (Ca2+ and Mg2+ free) and treated with 0.25% trypsin for 1 hour 
at 37ºC. After incubation the trypsin was aspirated off and replaced with Dulbecco’s minimum 
essential Eagle medium (DMEM) with 10% phosphate buffered solution (PBS) and 100 U/ml 
penicillin-streptomycin. The cells were loosened with gentle pipetting and seeded onto six-well 
tissue culture dishes, where they were incubated at 37ºC in 5% CO2 in DMEM with 10% FBS 
and 100 U/ml penicillin-streptomycin and the media changed every 3-4 days. When the cells 
became confluent, they were dissociated from the culture plate using 0.05% trypsin-EDTA, 
washed, and seeded onto the lens capsules and hydrogels in 24-well tissue culture dishes at a 
density of 6 x 105 cells/ml and incubated in the same conditions as before. The cells were found 
to adhere to and grow well on both surfaces tested, attaching within 24 hours and forming 
confluent epithelioid monolayers over a period of 4-5 days. This protocol is recommended for 
anyone wishing to perform drug treatment tests or RPE transplantation experiments, based on the 
highly epithelioid structure of the cell culture. 
Tseng et al. (2004) reported an RPE culture grown from cells obtained by the 
evisceration of two living humans during surgery. In both cases, the choroidal membrane was 
removed and stored in F12 medium. In the first case, the choroid was then cut into small pieces, 
which were plated in a 35 mm Falcon dish with 20% FBS F12 medium. Within 7 days of 
incubation, cells had migrated from the tissue and formed colonies with heterogeneous 
morphology, including pigmented epithelioid and fibroblast-like (fusiform) cells. The fibroblast-
like cells were capable of propagating and outnumbered the RPE cells 10 days after culture. In 
the second case, the choroid was digested in 0.25% trypsin for 30 minutes at 37°C to detach the 
RPE from the stroma, centrifuged, and resuspended in 20% FBS F12 medium. Pigmented cells 
attached to the culture dish overnight after seeding and began spreading in both polygonal and 
epithelioid morphologies after 3 days. The adherent cells began dividing 5 days after incubation, 
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losing pigmentation with growth and reaching confluence after 15 days. Subculturing resulted in 
further growth and continued epithelioid morphology. The cells became senescent after 6 
passages. In both cases, media was added and renewed every 3 days until confluence. This 
protocol is recommended for drug experimentation, due to the successful growth of RPE cells 
with a 6-passage Hayflick limit. 
Akrami et al. (2009) cultivated human RPE cells in vitro in order to produce retinal stem 
cells. The RPEs were obtained by opening the eyes (obtained from cadavers 24 hours after death) 
removing the neural retina with forceps, then washing the interior of the eyeball globe with PBS. 
The RPE layer was pulled out with forceps and cut into small sections, which were then 
incubated for 90 minutes at 37°C in 2 u/ml dispase. The resulting cell suspension was 
centrifuged for 5 minutes at 300 g and 4°C, and the pelleted cells placed in T25 flasks coated 
with FCS. The culture media used was DMEM:F12 supplemented with FCS (20% at the 
beginning of the culture, 10% with all medium changes afterward), penicillin, streptomycin, 
gentamicin, and amphotericin. The media was changed twice a week until the cells reached 
confluence (usually within 2-3 weeks), after which they were passaged into new T25 flasks using 
3x105 cells as the standard concentration per flask. The confluent cells formed an epithelioid 
monolayer but showed some loss of pigmentation, and also formed spheroid colonies indicative 
of the presence of stem/progenitor cells. This protocol would be best suited for growth of such 
stem cells for the production of self-renewing RPE tissue. 
Salero et al. (2012) found human retinal pigment epithelial cells to contain stem-like 
cells, which were found after RPE was isolated from adult donor eyes (some from cadavers as 
much as 99 years old) obtained from eye banks using the method found in Mannagh et al. 
(1973). After dissection, the RPE cells were dissociated and plated in adherent conditions, then 
grown using serum. The cells grew well, doubling once every 2 days, and could be passaged at 
least 6-8 times. The cultures formed pigmented epithelioid monolayers similar to those found in 
the living eye. From some of these monolayers, cells were then isolated, dissociated, and grown 
again at clonal density in nonadherent conditions, supplemented with knockout serum 
replacement medium (KSR).  This resulted in the development of spheroid colonies, which were 
found to demonstrate self-renewing properties when recultured. Other cultured epithelioid 
monolayers received treatment for 4 weeks with differentiation media resulted in cell markers 
being detected for neural, adipocyte, chondrocyte, and osteogenic cells. Similarity was found 
between the growth of cells from both young and elderly donors. This protocol would be useful 
for growing both natural-type RPE cells and stem cells for AMD treatment. 
Maminishkis et al. (2006) used fetal eyes in an attempt to establish a reproducible 
protocol for culturing human fetal RPE cells to resemble native tissue. The eyes were obtained 
from random donors, all used less than 26 hours after enucleation. The eyes were rinsed in 
antibiotic-antimycotic solution for 3-5 minutes, then rinsed twice with medium or PBS to remove 
the antibiotic. The anterior portion of the eye was removed (as in Mannagh et al. (1973)) and the 
posterior portion incubated in dispase-I solution for 30 minutes. The posterior poles were then 
placed in 5%-serum-containing “RPE medium” (a specific medium described in (Maminishkis et 
al. (2006)) and dissected in quadrants, the retina and RPE monolayer removed with forceps. The 
RPE sheets were then placed in 5%-serum-containing RPE medium, and centrifuged at 100 g, 
pipetted gently to separate the cells from the syncytium with or without trypsin treatment), and 
then placed in flasks with 15%-serum-containing RPE medium. After one day, the medium was 
replaced with 5%-serum-containing RPE medium, which was changed every 3 to 4 days 
afterward. They reported confluence and uniform pigmentation after 3-4 weeks, after which they 
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were trypsinized and passaged. The resulting cells formed confluent monolayers with epithelial 
morphologies and heavy pigmentation, with the apical membrane microvilli found in natural 
RPE. This protocol would be most suitable for drug experimentation and transplantation studies, 
based on the successful production of epithelioid monolayers. 
Gamm et al. (2008) also worked with human fetal RPE cells, searching for a serum-free 
system for growing human RPE. The eyes were taken from fetuses between 10 and 16 weeks of 
gestation, obtained from The University of Washington Birth Defects Laboratory and shipped 
overnight at 4°C. The eyes were dissected in ice-cold DMEM:F12 and 1% antibiotic-antimycotic 
solution, removing the anterior section and vitreous as previously detailed. The eyecups were 
washed with DM twice and the neural retina removed by forceps, using irrigation with DM to 
loosen retinas that did not detach spontaneously during vitreous removal. The RPE and choroid 
were then removed with forceps, and treated in one of three ways: in the first treatment, the RPE-
choroid sheets were incubated in a 2% dispase-DM solution for 30 minutes at 37°C and washed 
in DM twice, then the choroid peeled off with forceps and the resulting isolated RPE sheets 
chopped into 200-µm sections with a McIlwain automated tissue chopper, then placed in 
laminin-coated tissue culture plastic in serum-free RPE DM medium (SFRM) supplemented with 
either 2% B27 (SFRM-B27) or 1% or 2% N2 (SFRM-N2) (both B27 and N2 are commercially-
available supplements). In the second treatment, the RPE-choroid sheets were immediately 
chopped into 200-µm sections without dispase digestion, and only those fragments containing 
large pieces of RPE were placed in laminin-coated tissue culture plastic flasks or wells, where 
they were also supplemented with one of the two medium supplements mentioned previously. In 
the third treatment (which was devised after observing the reactions of the cells to the previous 
two procedures) treatment two was modified in that the chopped RPE-choroid fragments were 
first placed in suspension culture in SFRM-B27, then placed in tissue culture dishes. Spherical 
tissue aggregates formed within hours and became uniformly pigmented after 2 to 4 weeks in 
culture. After each treatment, the cultures were incubated at 37°C and 5% CO2, similar to other 
procedures used by other researchers. In all treatments, both cells supplemented with B27 and 
cells supplemented with N2 showed outgrowth in the first passage, though in all subsequent 
passages only B27-supplemented cultures showed substantial continued expansion, and within 5 
days the cells became confluent and adopted a characteristic RPE morphology. Treatments 1 and 
2 were found to have strong disadvantages (adherence failure and contaminating choroidal cell 
colonies, respectively), while treatment 3 was found to overcome both these disadvantages. This 
protocol is recommended for drug treatment experimentation, due to its successful production of 
viable RPE cultures. 
In 2009, Sonoda et al. established a protocol for culturing and differentiating human fetal 
RPE cells. Their cells were obtained from corporation with preserved tissues taken from 18-20-
week-old fetuses, shipped within a day to the experimenters. The anterior portion of the eye 
(referred to as the cornea-iris complex) is cut off and the vitreous removed. The posterior eye 
cup is dissected into four quadrants using a razor blade before RPE-choroid layer is peeled from 
the retina with forceps (fig. 3). The sheets are then dipped in a holding buffer and placed in 2% 
dispase solution for 30 min at 37°C and 5% CO2. After the 30-minute period, the sheets were 
placed back in the holding buffer to deactivate the dispase, and the RPE peeled off from the 
choroid using forceps. The cells were suspended in 10% FBS RPE medium (RPMI medium) and 
placed in a T75 flask. 24 hours later, the medium is replaced with 5% FBS RPE medium to 
prevent cell overgrowth. Experimenters observed cell adhesion within those 24 hours. Within 14 
days, the cells formed a dense film, with hexagonal cell morphology. This protocol was found to 
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produce well-polarized RPE cells in a discrete monolayer, similar to that found in the human 
eye, useful for drug treatment and transplant experimentation. 
 
Nonhuman cell sources 
 
 While human cells are most desirable for forming anthropogenic RPE monolayers, the 
ethical issues and limited availability of human donors makes culturing retinal pigment epithelial 
cells from nonhuman animal donors a preferred alternative. RPE cells have been studied in 
nonhuman mammals[32], [59], [135]–[137], birds[1], [138], and amphibians[44], [112], [125], 
and have been successfully harvested and cultured from several species of animal [139]. They 
have been grown in vitro for about as long as people have been culturing human RPEs [140], and 
many of the protocols established for human cells are also suitable for the cultivation of animal 
RPEs. Oka et al. (1984) in addition to culturing human RPE cells in serum-free defined medium 
(see above section), also worked with bovine cells, with similar results. The dissection and cell-
harvesting process was the same as in human eyes, as were the culture conditions. Results 
showed bovine cells formed confluent monolayers which were grown and passaged accordingly, 
making this protocol also useful for drug treatment experimentation in nonhuman subjects. 
 Ho et al. (1997) cultured cells taken from pig eyes for use in experiments with RPE 
transplantation. The eyes were removed from 6-month old adult pigs and transported to the 
laboratory within 4 hours of death in Hank’s balanced salt solution (HBSS, Gibco, Grand Island, 
NY, USA). The eyeballs were enucleated and sterilized by rapid dipping in 70% ethanol, then 
air-dried and transferred to MEM PSF (Eagle’s minimum essential medium (Gibco) with 110 
U/ml penicillin G sodium, 0.1 mg/ml streptomycin sulfate, and 2.5 µg/ml fungizone (Sigma, St. 
Louis, MO, USA)), where they were dissected by removing the anterior part of the eye. The 
vitreous and neural retina were removed and the eye cup was washed with 10% FBS MEM PSF 
with gentle pipetting. RPE cells were harvested using a fire-polished pipette and the resulting 
suspension centrifuged for 5 minutes at 800 RPM. The cells were resuspended in MEM/10 PSF 
and placed in 60 mm tissue culture dishes for culturing. The cultures were incubated at 37°C and 
5% CO2 until they reached confluence, using MEM/10 PSF as medium, with supplements of 50 
mg/ml gentamicin (Sigma) and 1 ng/ml basic fibroblast growth factor (bFGF, Gibco). Cells 
reached confluence in 3-4 weeks for primary cultures, after which they were split 1:5 and 
passaged into 6 well plates or 60 mm culture dishes. First passage cells grown this way were then 
able to be harvested using 0.25% edetic acid (fig. 5) in Hank’s balanced salt solution (HBSS) and 
transferred to other culture dishes with high viability (96.7 ± 2.7% by Trypan blue exclusion). 
This protocol is recommended for experimentation with RPE transplants that do not use a solid 
substrate during transplantation. 
Singh et al. (2001) also used pig RPE cells (in addition to human cells, as detailed in the 
previous section). The cells were harvested 2-4 hours after death from pig eyes that had been 
soaked in sterile prepodyne solution 10 minutes before dissection. The cells were obtained by 
removing the anterior portion of the eye, followed by the vitreous and neural retina. The eyecup 
was then washed with HBSS and trypsinized with 0.25% trypsin for an hour at 37°C. The trypsin 
was then aspirated off and replaced with 10% FBS DMEM, which was then pipetted gently to 
remove the cells from the Bruch’s membrane. The RPE cells were seeded onto six-well tissue 
culture dishes and incubated at 37°C in 5% CO2 in 10% FBS DMEM, and the culture changed 
every 3-4 days. Passaging was performed using 0.05% trypsin-EDTA, and cells later plated onto 
human and porcine lens capsules and hydrogels at 6 x 105 cell/ml seeding densities. RPE cells 
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attached and proliferated well on both lens capsule and hydrogel surfaces, forming confluent 
monolayers of polygonal pigmented cells (fig. 6). This protocol is recommended for anyone 
wishing to perform drug treatment tests or RPE transplantation experiments, based on the highly 
epithelioid structure of the cell culture. 
 
 
Figure 5. Porcine RPE cells in suspension after 12 minutes in 0.25% edetic acid during passaging. Scale bar = 50 
µm. [117] 
 
 
Figure 6. Cultured porcine RPE cells, grown on a pig lens capsule (top) and a hydrogel (bottom) respectively, as 
found in Singh et al. (2001), Scale bar = 50 µm. [87] 
 
 Israel et al. (1980) cultured embryonic RPE cells from domestic chickens by dissecting 
embryos at stages 29-31 of development. The RPE cell sheets were removed from the other cells 
and dissociated in Coon’s collagenase-trypsin-chick serum-EDTA enzyme solution. The 
resulting suspension was plated in 3 ml of 5% FBS MEM or F12 medium on 60 mm plastic 
tissue culture dishes. The cells were incubated at 37.5°C in 5% CO2 and the medium replaced 
every 3 days. Cells grown in MEM were shown to form colonies of heavily pigmented cells that 
grew in epithelioid monolayers, while cells grown in F-12 were large, fibroblastic, and had little 
pigmentation. The protocol that resulted in the first type of cell is recommended for drug 
treatment experimentation, although its application to humans may be limited due to the different 
nature of the avian RPE cells. 
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Cell lines 
 
 An alternative to using cells from living or dead specimens is to culture cells that have 
already been transformed into cell lines. Immortalized RPE cells are available commercially, and 
often come with a standardized culturing protocol attached. One of the most commonly-used 
RPE cell lines is the ARPE-19 cell line, which was established from cells isolated from the 
enucleated globes of a 19-year-old male human donor 2 hours after death [142]. While ARPE-19 
cells have been used in many studies since the cell line was first established, they show some 
morphological and developmental differences from natural-type RPE cells [14], [42], [75], [77], 
[86], [143]–[145]. In general, immortalized cell lines have some physiological differences from 
natural cells, and may have different culturing requirements as well; however, variations in 
culturing technique are less prevalent than in human- and animal-derived cells, due to 
standardization of culture protocol for established cell lines. One of the most common problems 
with cell-line-derived RPE cells is a lack of pigmentation and different morphological 
characteristics than those found in natural RPE; however, it is possible to induce immortalized 
cells to form pigmented epithelioid monolayers, as shown in the examples below. 
RPE cells can also form cell lines spontaneously, as found by Mannagh et al. (1973) who 
observed that of the 119 primary RPE cultures they managed to establish from human donors, 7 
spontaneously transformed into cell lines. The researchers found the cells became smaller and 
more uniform upon transformation, as well as more closely spaced, and began demonstrating 
accelerated growth, approximately halving their generation time. They also discovered that the 
transformed cells remained in a monolayer and gradually replaced the remaining primary culture 
cells. Further study showed that the transformed cells had changed from diploid to heteroploid, a 
common indication of transformation of a primary culture into a cell line. Two of the cell lines 
established by the study survived into later years, and came from a 70-year-old and 21-year-old 
donor respectively. This tendency of RPE cells to spontaneously form cell lines has been 
observed in multiple instances [118], [142], and the cells produced by such cell lines are 
recommended for drug treatment experiments. 
 Tezcaner et al. (2003) cultured cell-line-grown RPE cells with the goal of providing 
transplants for RPE disorder patients, using cells from the D407 cell line. The cells were cultured 
in 5% FBS DMEM in a 5% CO2 atmosphere, and passaged using 0.05% trypsin-EDTA. The 
cultures were grown on thin surface-modified and un-modified PHBV8 films that were kept in 
24 well plates, with Teflon O-rings placed on top to prevent the films from floating after medium 
was added. The cells were seeded at a concentration range of 8.5 x103-45x103 cells/cm2. Both the 
films and the O-rings were sterilized using 20 minutes of UV radiation. When the cells reached 
confluence, they were passaged using 0.05% trypsin-EDTA, with a reattachment rate of 25 x 103 
cells/cm2 after 8 hours of incubation. This increase in reattachment rate with time was only found 
to occur within the previously-mentioned seeding density range, and the PHBV8 films treated 
with 100 W oxygen plasma for 10 minutes (the smoothest substrate used in this experiment) 
were found to have the greatest success in cell reattachment and growth, forming confluent 
monolayers within 7 days. This protocol is recommended for experiments with drug treatments 
and transplantation using cell lines, due to the successful formation of confluent monolayers. 
 Tian et al. (2005) used the ARPE-19 cell line, cultivating the cells in order to check for 
transcriptional differences between the cell line and native RPE from fresh cadaver eyes. All 
ARPE-19 cells were seeded at 10,000 cells/cm2 or 1000,000 cells/cm2 for 3 days in T75 flasks in 
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10% FBS DMEM:F12 and incubated at 37°C in 10% CO2. Confluent cultures were then grown 
for 7 days, and then their medium was replaced with fresh medium containing either serum (CS 
treatment) or 1% bovine serum albumin (CSW) for 3 days. Other cells were grown for 2.5 
months in 10% FBS DMEM:F12 medium, and then in either serum (DS) or 1% bovine serum 
albumin (BSA) (DSW) for 3 days. Results showed ARPE-19 cells grown on plastic to have 
fewer transcriptional differences with native RPE than ARPE-19s grown on other surfaces, and 
that the two treatments with the fewest transcriptional differences with native RPE were CSW 
and DSW. However, the DS culture showed the greatest morphological similarities to native 
RPE, displaying a tight mosaic-like monolayer configuration with polygonal, columnar, highly 
pigmented cells. Due to these results, the protocol is recommended for drug treatment 
experiments, particularly where transcriptional differences are an issue. 
 Amemiya et al. (2004) cultured cells of the ARPE-19 and H80HrPE cell lines in 8% heat-
inactivated FBS 1% penicillin-streptomycin MEM at 37°C with 5% CO2. The medium was 
changed every 3 days, and the cells were found to form a viable epithelioid monolayer and 
remained healthy after freezing and thawing. They developed pigmentation after 5 months of 
culture and, when examined immunocytochemically, showed immunoreactivity for some 
epithelial cell markers. This protocol is recommended for drug treatment experiments involving 
cell markers. 
 
Results and Conclusions 
 
 The various RPE culture protocols examined in this review are summarized in the 
following section. While each method was successful in producing a culture of viable RPE cells, 
differences in resulting cell life, morphology, function, and structure make different methods 
preferable for a researcher desiring a specific type of culture. The effects of cell source, 
preparation and extraction method, culture medium, substrate, incubation, and passaging are 
evaluated in the conclusions section. 
 
Summary of methods 
 
 Each method for culturing RPE cells reviewed is summarized in Table 1 (Appendix). 
Results of each method are summarized in Table 2 (Appendix). 
 
Cell sources and extraction methods 
 
 According to the literature, use of cells from all sources listed resulted in viable cultures. 
For human cells, both adult and fetal cells grew well, and removal from eyeballs was generally 
accomplished by first peeling off the RPE and choroid as a single sheet, then dicing/mincing the 
tissue with a scalpel, with or without digestion by some digestive enzyme first (trypsin or 
dispase). Nonhuman cells, on the other hand, were more often digested and then dissociated with 
pipetting, either in the eyecup or after the RPE-choroid sheet had been removed. Cultures from 
cell lines were generally less complicated to begin, due to the lack of need for dissection or 
dissociation, but often led to alterations in cell morphology, including loss of pigmentation, 
though this may be overcome. There is no indication that one cell source is better than another 
for increasing chances of adhesion and growth, though with dead specimens freshness is highly 
desired for a viable culture. 
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Culture media 
  
 In general, the medium used was either a form of Modified Eagle’s Medium (MEM) 
often supplemented with FBS or some other serum, or a mix specific to the publication without a 
standardized name. Concentrations of supplemental sera varied from 5% to 20%, and other 
supplements included streptomycin, penicillin, and other antibiotics that helped prevent 
contamination. No general trend was seen indicating the success of one medium over another in 
cell growth, though differences in cell morphology and growth rate were seen in relation with 
different medium mixtures, and the same media may react differently to human and nonhuman 
RPE. 
 
Substrates and incubation 
 
 Well-plates, culture dishes, and flasks (either T25 or T75) were the most common growth 
substrates used. Each demonstrated successful cell attachment and growth. At least one study 
[146] found the smoothest substrate to be the most effective in inducing cell attachment. Others 
[87], [133] found a more irregular surface more conducive to cell adhesion and the development 
of polygonal, epithelioid cell morphologies. This variation in adhesion potential may be due to 
the surface resembling Bruch’s membrane that natural RPE cells adhere to. Incubation was 
performed almost universally at 37°C and 5% CO2, even for nonhuman cells, the exception 
being Israel et al. (1980), who incubated avian RPE cells at 37.5°C. Medium change intervals 
ranged from 2-4 days, with no difference in cell growth detected between variations. 
 
Passaging 
 
 Of the cells successfully passaged, the most commonly-used dissolving agent was 
trypsin, ranging in concentration (in EDTA) from 0.05% to 0.25%. Most cultures were passaged 
at confluence, with successful cell reattachment and growth on the new surface. Cultures took 
between 5-30 days to reach confluence, depending on the size of the surface they were grown. 
Seeding concentrations ranged from 8.5x103 to 6x105 cells/ml, with successful adhesion and cell 
growth within that range. On average, non-immortalized cells were able to go through 4-7 
passages before growth ceased and cells became senescent, often altering their morphology at 
this point. 
 
Conclusion 
 
 The science of RPE cell culture, despite having been practiced for over four decades at 
the time of this writing, remains an experimental process. Researchers are still attempting to 
discover the correct combination of conditions, chemicals, and procedures to produce an 
artificial RPE best suited for macular degeneration testing. While there is still territory left to 
explore, a few standards have been established that can be used as guidelines for a cell scientist 
wishing to recreate the RPE in vitro.  
First, while pigmentation loss and degradation of the epithelioid formation are common 
problems for cells harvested from living or cadaverous tissue, both can be minimized with proper 
medium mixes and plating techniques. While cells from cell lines often differ from their parent 
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tissue, some differences (such as pigmentation and cell shape) can be fixed by manipulating 
culture conditions. RPE cells can be grown to form confluent epithelioid monolayers on a variety 
of surfaces and in a variety of media, though DMEM and its variations were the most 
commonly-used medium. Cultured RPEs can be grown to confluence and successfully passaged, 
and have been shown to be able to produce cell lines and retinal stem cells, and while no cultured 
RPE monolayer has been successfully transplanted into a human eye yet, as culturing techniques 
improve the cells come closer to the state found in the natural RPE, making such future surgical 
endeavors a possibility. Ultimately, the path to devising the ideal culture protocol for 
approximating the natural human RPE can only be found through further experimentation. Using 
this review as a guide will greatly aid researchers attempting to further research into the retina 
and AMD treatment. 
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